Institute for Antibodies Co Ltd - Company Review
SummaryInstitute for Antibodies Co Ltd - Company Review
Summary
Institute for Antibodies Co Ltd (IFA), a subsidiary of Medical & Biological Laboratories Co Ltd is a healthcare solutions provider that develops technologies. The company develops technologies for the production of various types of antigens and antibodies. Its antibody based technology is used for prevention and treatment of different types of diseases. IFA develops technologies to create antibodies against any antigens. IFA develops technologies to create additional valuable antibodies that can neutralize viruses and toxins. It has identified antigens by double immunostaining using an antibody to green fluorescent protein and an antibody fused to red fluorescent protein. IFA is headquartered in Nagoya, Japan.
This comprehensive company report of Institute for Antibodies Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.